4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-16-110485
CIK 0001492426operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 6:52 PM ET
Size
8.0 KB
Accession
0001209191-16-110485
Insider Transaction Report
Form 4
Kelly David George
EVP & Corporate Secretary
Transactions
- Exercise/Conversion
Ordinary Shares
2016-03-23+19,250→ 19,250 total(indirect: By Trust) - Exercise/Conversion
Restricted Stock Units
2016-03-23−19,250→ 57,750 total→ Ordinary Shares (19,250 underlying)
Holdings
- 125,888
Ordinary Shares
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On March 23, 2015, the reporting person was granted 77,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 6:52 PM ET
- Size
- 8.0 KB